Clinical Trial Update: Etanercept for Wegener's Granulomatosis [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 trials evaluating etanercept for granulomatosis with polyangiitis (Wegener's granulomatosis) have been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatosis with Polyangiitis

Drugs mentioned

• Etanercept (etanercept)

Snippet

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Conditions: Wegener's Granulomatosis | Phase 2, Phase 3 | Status: COMPLETED